Dongguan HEC TaiGen BiopharmaceuticalsOrganizationGet new research by emailTrialsNCT04155515Phase 3, Completed, 370 people, Nov 7, 2019NCT03593447Phase 2, Completed, 133 people, Jul 20, 2018